The Catalyst

Most Recent Posts

06.11.12 | By John Castellani

I can still vividly remember the year Congress declared war on cancer. It was 1971 and I was a few months away from graduation at my college in upstate New York. There wasn't a lot of optimism in the country then - we were in the middle of the Vietnam War and protests were taking place on college campuses across the country, including my own.

06.08.12 | By Preet Bilinski

Today we have a Q&A with Ryan M. Hohman, JD, MPA, Director, Communications & Policy at Friends of Cancer Research (Friends), a patient advocacy organization and think tank based in Washington, DC.

06.08.12 | By Preet Bilinski

Recently PhRMA staff volunteered at the Special Olympics of DC (SODC) Summer Games. And as excited as the SODC was regarding our participation, my colleagues were even more thrilled to be there. This was PhRMA's first time being involved with the games and it was such an amazing experience. You can hear from a few of my colleagues below.

06.07.12 | By Jennifer Wall

Marv Shepherd, PhD, president of the Partnership for Safe Medicines, comments on World Anti Counterfeiting Day.

06.05.12 | By Jennifer Wall

We believe it is only fitting that on the last day of the American Society of Clinical Oncologist's (ASCO) annual meeting that the researchers and developers of life-enhancing medicines - biopharmaceutical research companies - highlight the progress that has been made in the war against cancer.

06.05.12 | By Kate Connors

In The Hill today, reporter Elise Viebeck reports from the recent American Society of Clinical Oncology meeting about the increasing number of new cancer medicines reaching the Food and Drug Administration

06.05.12 | By Preet Bilinski

Today we have guest post from cancer survivor Susan Parkinson, who talks about her battle with Non-Hodgkin's Lymphoma (NHL).

06.04.12 | By Preet Bilinski

Cancer poses a major public health challenge for us as individuals, our economy and our society as a whole. Over the next several days, we will be devoting a page on our website to cancer week: Medicines in Development for Cancer.

06.01.12

National Cancer Survivors Day is Sunday, June 3. It is an annual celebration of life to show the world that there is life after a cancer diagnosis. And I, Jeff Trewhitt, am a proud cancer survivor. Here's a look at my life after cancer.

06.01.12 | By Kate Connors

Yesterday, someone brought to my attention a really interesting study in The Journal of Clinical Hypertension. It evaluated how much the prescribing decisions of physicians are influenced by the information provided to them by biopharmaceutical company sales representatives.

06.01.12 | By Preet Bilinski

Today, thanks in part to the work done in biopharmaceutical research and development, there are a record number of Americans surviving cancer: nearly 12 million. Despite this progress, cancer remains the second leading cause of death by disease in the United States, exceeded only by heart disease.

05.31.12 | By Preet Bilinski

Unfortunately, today most of us know someone that has had to battle cancer. On the bright side, more and more people are winning that fight. We've come a long way since signs of cancer were found in the bones of mummies from ancient Egypt, to declaring war on cancer, to approving vaccines for cancer.

05.30.12 | By Greg Lopes

The Los Angeles Times recently ran a provoking story on insurance company coverage of specialty medicines and the increasing share of the cost patient

05.30.12 | By Jon Tripp

The 2012 Pharmaceutical Industry Profile is now available as a free interactive e-book on the popular iTunes Bookstore.

05.29.12 | By Kate Connors

This year, one of the key topics of conversation at our annual meeting was the importance of collaboration among different members of the research ecosystem - and rightly so, as this collaboration

Pages